Apogee Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Apr '25 Apr 25, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	2,141	2,578	1,342	-
Market Cap Growth	92.14%	92.14%	-	-
Enterprise Value	1,421	1,836	919	-
Last Close Price	36.85	45.30	27.94	-
PB Ratio	2.98	3.60	3.53	-
P/TBV Ratio	2.99	3.60	3.53	-
Debt / Equity Ratio	0.02	0.02	0.01	-
Quick Ratio	18.40	18.40	19.30	15.22
Current Ratio	18.55	18.55	19.38	15.24
Return on Equity (ROE)	-33.22%	-33.22%	-32.18%	-
Return on Assets (ROA)	-23.46%	-23.46%	-21.00%	-
Return on Capital (ROIC)	-24.41%	-24.41%	-22.18%	-
Earnings Yield	-8.51%	-7.07%	-6.26%	-
FCF Yield	-8.05%	-6.69%	-5.58%	-
Buyback Yield / Dilution	-120.72%	-120.72%	-915.57%	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q